Switzerland, Nordics and Singapore Lead New Global Investment Risk and Resilience Index
LONDON, Oct. 21, 2025 /PRNewswire/ -- Switzerland is ranked the world's most resilient country in the new Global Investment Risk and Resilience Index, with Denmark, Norway, Singapore, and Sweden completing the Top Five. The index is the first of its...
Google AI Breakthrough Highlights Silmitasertib (CX-4945) as a Novel Pathway in Cancer Immunotherapy
TAIPEI and SAN DIEGO, Oct. 21, 2025 /PRNewswire/ -- Senhwa Biosciences's investigational new drug Silmitasertib (CX-4945) was recently featured in an official post by Google DeepMind, following a major breakthrough by the tech giant's biological...
Zero Formalin Specimen Preservation Solution for Formalin-Free Classrooms
BANGKOK, Oct. 21, 2025 /PRNewswire/ -- Anatomy instructors at the Faculty of Veterinary Science , Chulalongkorn University , have developed Zero Formalin (ZF)—a formalin-free animal specimen preservation solution—to create safer classrooms and...
CUHK Business School launches pioneering MSc in Leadership for Experience Economy
HONG KONG, Oct. 20, 2025 /PRNewswire/ -- The Chinese University of Hong Kong (CUHK) Business School is pleased to announce the launch of its new Master of Science (MSc) in Leadership for Experience Economy (LEE) programme, with its first intake...
International Technology Night: OMODA&JAECOO Leverage Power and Smart Mobility to Lead a New Wave of User Co-Creation
KUALA LUMPUR, Malaysia and WUHU, China, Oct. 19, 2025 /PRNewswire/ -- In October 2025, the OMODA&JAECOO International User Summit was grandly held to worldwide attention, with the International Technology Night becoming the highlight of the...
Case Report | Preliminary Clinical Data of CARsgen's Allogeneic BCMA CAR-T Product CT0596 for the Treatment of Primary Plasma Cell Leukemia
SHANGHAI, Oct. 19, 2025 /PRNewswire/ -- Primary plasma cell leukemia (pPCL) is a rare and highly aggressive plasma cell malignancy, often associated with complex genetic abnormalities. There is currently no standard treatment regimens, and...
Research Updates on a Phase III Clinical Trial of Anbenitamab (KN026) Presented at ESMO Congress 2025 LBA Oral Presentation Session
SUZHOU, China, Oct. 18, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the first interim analysis results of a phase III clinical trial of anbenitamab injection (KN026), independently developed by the Company and...
Patented Innovation Empowers Home Creators Delivering Professional Customization with Simplified Operation and Friendly Pricing
NEW YORK, Oct. 17, 2025 /PRNewswire/ -- VEVOR, a leading home improvement brand empowering home creators worldwide, announced the launch of its Hybrid Heat Press, a patented heat transfer machine designed to make professional-grade customization...
Wang Qunbin: Innovation-Driven, Fosun's Path to Globalization
HONG KONG, Oct. 17, 2025 /PRNewswire/ -- On 16 October, the 2025 Sustainability Global Leaders Conference was held in Shanghai. Themed "Joining Hands to Address Challenges: Global Action, Innovation, and Sustainable Growth", the Conference brought...
G42 Provides Update on Construction of Stargate UAE AI Infrastructure Cluster
The facility is part of the larger 5GW UAE–U.S. AI Campus in Abu Dhabi ABU DHABI, UAE, Oct. 16, 2025 /PRNewswire/ -- G42 today announced major progress on the construction of Stargate UAE, a 1GW large-scale AI infrastructure cluster being developed...